EICHORCondition: Chronic Fatigue Syndrome · Cognitive Impairments · Sponsor: Rochester Center for Behavioral Medicine
Sponsor, CRO or site team? See where this study is running → — listed sites, countries and recruiting context. Everything below is written for patients and caregivers.
Over the past decade, the Rochester Center for Behavioral Medicine (RCBM) has evaluated many patients with attention deficit hyperactivity disorder (ADHD). A recurrent finding in these patients is a history of unexplained fatigue and musculoskeletal pain. Treatment of these patients in our clinic has revealed that when their underlying ADHD is treated with psychostimulant medication, many patients report significant improvements with regard to their fatigue and musculoskeletal pain. Patients report less subjective fatigue and pain and note overall functional improvement, although the initial and primary objective was the treatment of their attention or hyperactivity problems. We speculate that stimulants are efficacious by offering two distinct clinical properties. 1) anti-fatigue properties and 2) properties that allow patients to filter out extraneous stimuli (i.e. chronic muscle pain).
This description comes directly from the study's public registry record.
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
Inclusion Criteria: * BRIEF-A Global Executive Composite score (GEC) ≥ 65, or Behavioral Regulation Index score (BRI) ≥ 65, or Metacognition Index score (MI) ≥ 65. * Subjects must meet consensus criteria for chronic fatigue syndrome. * Provide written informed consent for participation in the trial before completing any study-related procedures. * 18-60 years at time of consent * Male or non-pregnant females who are not breastfeeding. * Females of reproductive potential must agree to use a medically accepted means of contraception when engaging in sexual intercourse at any time during the study. * Are able to swallow study medication. Exclusion Criteria: * CFS and executive functioning impairment are not present or not diagnosable * Serious comorbid psychiatric condition * Subjects who were pregnant, nursing, or intended to become pregnant * Subjects who had been on a psychostimulant regimen in the last six months * Subjects who had a medical condition that would have been affected by psychostimulant medication * Subjects who were of low intelligence, or who were unable to communicate effectively with the study team
Reproduced word-for-word from the public registry record — the study team can answer questions about it.
| Rochester Center for Behavioral Medicine | Rochester Hills, Michigan, United States | — |
This study lists sites in the areas below. Each link shows other recruiting studies near that city, from the public registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT01071044